Skip to content

Randomized Trial of Two Analgesics in Elderly ED Patients

Randomized Trial of Two Analgesics in Elderly ED Patients

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02703610
Enrollment
0
Registered
2016-03-09
Start date
2024-07-01
Completion date
2026-07-30
Last updated
2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Pain, Elderly

Brief summary

The purpose of this study is to perform a randomized, double blind 2-arm clinical trial of the comparative efficacy of 2 oral analgesics in the the management of acute pain in elderly patients who present and then are discharged from the ED.

Detailed description

To perform a randomized, double blind 2-arm clinical trial of the comparative efficacy of 2 oral analgesics in the the management of acute pain in elderly patients who present and then are discharged from the ED.. The 2 groups are as follows: 1. Oxycodone/acetaminophen (5/325) 2. Ibuprofen/acetaminophen (400/500)

Interventions

Patients will be discharged home with a 3 day supply of oxycodone/acetaminophen

Patients will be discharged home with a 3 day supply of ibuprofen/acetaminophen

Sponsors

Albany Medical College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Complaint of acute pain of \< 7 days duration * ED attending plans to discharge patient home with an oral analgesic

Exclusion criteria

* Inability to confirm reliable means of phone followup. * Past use of methadone * Chronic condition requiring frequent pain management such as sickle cell disease, fibromyalgia, or any neuropathy * History of an adverse reaction to any of the study medications * Ibuprofen or acetaminophen or opioids taken in past 4 hours * History of peptic ulcer disease * Report of any prior use of recreational narcotics * Medical condition that might affect metabolism of opioid analgesics, acetaminophen, or ibuprofen such as hepatitis, renal insufficiency, hypo- or hyperthyroidism, Addison's or Cushing's disease

Design outcomes

Primary

MeasureTime frameDescription
Between group difference in change in NRS pain scores24 hoursBetween group difference in change in NRS pain scores at 24 hours

Secondary

MeasureTime frameDescription
Between group difference in change in NRS pain scores48 hours and 72 hoursBetween group difference in change in NRS pain scores at 48 hours and 72 hours
Between group difference in side effects24 hours, 48 hours and 72 hoursProportion with side effects (nausea, vomiting, pruritus, dizziness, drowsiness, constipation)
Change in NRS pre and 2 hours post most recent dose of pain medication taken24 hoursChange in NRS pre and 2 hours post most recent dose of pain medication taken
Between group difference in Likert pain scores24, 48, and 72 hoursPain evaluation on a 4 point Likert scale (none, mild, moderate, severe)
Between group difference in change in NRS pain scores at first followup contact24-72 hoursBetween group difference in change in NRS pain scores at first followup contact
Between group differences in NRS pain scores in patients who have extremity injuries, extremity fractures, and 10/10 pain.24-72 hoursBetween group differences in NRS pain scores in patients who have extremity injuries, extremity fractures, and 10/10 pain.
Difference in percentage of physicians and patients in each group who successfully identified which study group the patient had been randomized to24-72 hoursDifference in percentage of physicians and patients in each group who successfully identified which study group the patient had been randomized to
Want same medication again24-72 hoursBetween group difference in proportion of patients who would want the same medication again
Satisfaction24, 48, and 72 hoursSatisfaction assessed by 4-point Likert Scale: very satisfied, satisfied, unsatisfied, very unsatisfied

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026